An optimized flow cytometry protocol for analysis of angiogenic monocytes and endothelial progenitor cells in peripheral blood

Cytometry Part A

Volumn 75, Issue 10, 2009, Pages 848-853

  Hristov, Mihail ^a   Schmitz, Susanne ^a   Schuhmann, Christoph ^b   Leyendecker, Thorsten ^a   Von Hundelshausen, Philipp ^a   Krötz, Florian ^b   Sohn, Hae Young ^b   Nauwelaers, Frans A ^c   Weber, Christian ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c BD Biosciences Europe ^*  (Belgium)

Author keywords

Angiogenesis; Atherosclerosis; Bone marrow; Leukocytes; Remodeling

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN RECEPTOR; CD14 ANTIGEN; CD16 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; FLUOROCHROME; VASCULOTROPIN RECEPTOR 2;

AGED; ANTIGEN PRESENTING CELL; ARTICLE; CELL POPULATION; CLINICAL ARTICLE; CONSENSUS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; MALE; MONOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; STEM CELL; TUMOR VASCULARIZATION; VENOUS BLOOD;

AGED; ANTIGENS, CD14; ANTIGENS, CD45; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MONOCYTES; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTOR, TIE-2; RECEPTORS, IGG; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 70349482344     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.20772     Document Type: Article

References (23)

1. Hristov M, Weber C. Endothelial progenitor cells in vascular repair and remodeling. Pharmacol Res 2008;58:148-151.
2. Timmermans F, Van Hauwermeiren F, De Smedt M, Raedt R, Plasschaert F, De Buyzere ML, Gillebert TC, Plum J, Vandekerckhove B. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Arterioscler Thromb Vasc Biol 2007;27:1572-1579. (Pubitemid 46986112)
3. Hirschi KK, Ingram DA, Yoder MC. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2008;28:1584-1595.
4. Bertolini F, Shaked Y, Mancuso P, Kerbel RS. The multifaceted circulating endothelial cell in cancer: towards marker and target identification. Nat Rev Cancer 2006;6:835-845. (Pubitemid 44629895)
5. Case J, Mead LE, Bessler WK, Prater D, White HA, Saadatzadeh MR, Bhavsar JR, Yoder MC, Haneline LS, Ingram DA. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 2007;35:1109-1118.
6. Schmidt-Lucke C, Rössig L, Fichtlscherer S, Vasa M, Britten M, Kämper U, Dimmeler S, Zeiher AM. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: Proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005;111:2981-2987. (Pubitemid 40814192)
7. Xiao Q, Kiechl S, Patel S, Oberhollenzer F, Weger S, Mayr A, Metzler B, Reindl M, Hu Y, Willeit J, Xu Q. Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis - Results from a large population-based study. PLoS ONE 2007;2:e975.
8. Güven H, Shepherd RM, Bach RG, Capoccia BJ, Link DC. The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. J Am Coll Cardiol 2006;48:1579-1587. (Pubitemid 44528190)
9. Hristov M, Fach C, Becker C, Heussen N, Liehn EA, Blindt R, Hanrath P, Weber C. Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment. Atherosclerosis 2007;192:413-420. (Pubitemid 46726323)
10. Whittaker A, Moore JS, Vasa-Nicotera M, Stevens S, Samani NJ. Evidence for genetic regulation of endothelial progenitor cells and their role as biological markers of atherosclerotic susceptibility. Eur Heart J 2008;29:332-338. (Pubitemid 351197761)
11. Hristov M, Weber C. Endothelial progenitor cells: Cellular biomarkers in vascular disease. Drug Discov Today 2008;5:e267-e271.
12. Weber C, Belge KU, von Hundelshausen P, Draude G, Steppich B, Mack M, Frankenberger M, Weber KS, Ziegler-Heitbrock HW. Differential chemokine receptor expression and function in human monocyte subpopulations. J Leukoc Biol 2000;67:699-704. (Pubitemid 30679765)
13. Ziegler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 2007;81:584-592. (Pubitemid 46393535)
14. De Palma M, Murdoch C, Venneri MA, Naldini L, Lewis CE. Tie2-expressing monocytes: Regulation of tumor angiogenesis and therapeutic implications. Trends Immunol 2007;28:519-524. (Pubitemid 350101421)
15. Murdoch C, Tazzyman S, Webster S, Lewis CE. Expression of Tie-2 by human monocytes and their responses to angiopoietin-2. J Immunol 2007;178:7405-7411. (Pubitemid 46847468)
16. Venneri MA, De Palma M, Ponzoni M, Pucci F, Scielzo C, Zonari E, Mazzieri R, Doglioni C, Naldini L. Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer. Blood 2007;109:5276-5285. (Pubitemid 46890548)
17. Khan SS, Solomon MA, McCoy JP Jr. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry Part B: Clin Cytom 2005;64B:1-8.
18. Van Craenenbroeck EM, Conraads VM, Van Bockstaele DR, Haine SE, Vermeulen K, Van Tendeloo VF, Vrints CJ, Hoymans VY. Quantification of circulating endothelial progenitor cells: A methodological comparison of six flow cytometric approaches. J Immunol Methods 2008;332:31-40.
19. Möbius-Winkler S, Höllriegel R, Schuler G, Adams V. Endothelial progenitor cells: Implications for cardiovascular disease. Cytometry Part A 2009;75A:25-37.
20. Boilson BA, Kiernan TJ, Harbuzariu A, Nelson RE, Lerman A, Simari RD. Circulating CD34+ cell subsets in patients with coronary endothelial dysfunction. Nat Clin Pract Cardiovasc Med 2008;5:489-496.
21. Chironi G, Walch L, Pernollet MG, Gariepy J, Levenson J, Rendu F, Simon A. Decreased number of circulating CD34+KDR+ cells in asymptomatic subjects with preclinical atherosclerosis. Atherosclerosis 2007;191:115-120. (Pubitemid 46237627)
22. Maecker HT, Trotter J. Flow cytometry controls, instrument setup, and the determination of positivity. Cytometry Part A 2006;69A:1037-1042. (Pubitemid 44521985)
23. Maecker HT, Frey T, Nomura LE, Trotter J. Selecting fluorochrome conjugates for maximum sensitivity. Cytometry Part A 2004;62A:169-173. (Pubitemid 39579247)